Arthroscopic debridement of the osteoarthritic knee combined with hyaluronic acid (Orthovisc) treatment: a case series and review of the literature.
OBJECTIVE
An evaluation of safety and efficacy of high molecular weight hyaluronan (HA) delivered at the time of arthroscopic debridement of the osteoarthritic knee.


METHODS
Thirty consecutive patients who met inclusion and exclusion criteria underwent arthroscopic debridement by a single surgeon and concomitant delivery of 6 ml/90 mg HA (Orthovisc). These patients were evaluated preoperatively, at 6 weeks, 3 and 6 months post-operatively. Evaluations consisted of WOMAC pain score, SF-36 Physical Component Summary (PCS) score and complications.


RESULTS
No complications occurred during this study. Pre-op average WOMAC pain score was 6.8 +/- 3.5 (n = 30) with a reduction to 3.4 +/- 3.1 at 6 weeks (n = 27). Final average WOMAC pain score improved to 3.2 +/- 3.8 at six months (n = 23). No patients had deterioration of the WOMAC pain score. Mean pre-operative SF-36 PCS score was 39.0 +/- 10.4 with SF-36 PCS score of the bottom 25th percentile at 29.9 (n = 30). Post procedure and HA delivery, mean PCS score at 6 weeks improved to 43.7 +/- 8.0 with the bottom 25th percentile at 37.5 (n = 27). At 6 months, mean PCS score was 48.0 +/- 9.8 with the bottom 25th percentile improved to 45.8 (n = 23).


CONCLUSIONS
The results show that concomitant delivery of high molecular weight hyaluronan (Orthovisc--6 ml/90 mg) is safe when given at the time of arthroscopic debridement of the osteoarthritic knee. By delivering HA (Orthovisc) at the time of the arthroscopic debridement, there may be a decreased risk of joint infection and/or injection site pain. Furthermore, the combination of both procedures show efficacy in reducing WOMAC pain scores and improving SF-36 PCS scores over a six month period.
Li
Xinning
X
Division of Sports Medicine, Department of Orthopaedic Surgery, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA. xinning.li@gmail.com
Shah
Agam
A
Franklin
Patricia
P
Merolli
Renee
R
Bradley
Jill
J
Busconi
Brian
B
Clin Orthop Relat Res. 2001 Apr;(385):130-43
11302304
Arthroscopy. 2003 Jan;19(1):13-20
12522398
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005321
15846754
J Orthop Res. 2008 Dec;26(12):1643-8
18524010
Int Orthop. 2001;25(4):242-5
11561500
J Bone Joint Surg Am. 2006 May;88(5):936-43
16651566
Knee Surg Sports Traumatol Arthrosc. 2006 Jan;14(1):32-9
15918064
Rheumatology (Oxford). 2003 Dec;42(12):1477-85
12867587
J Bone Joint Surg Am. 2003 Jan;85(1):10-9
12533566
Knee. 2003 Sep;10(3):291-3
12893153
Knee Surg Sports Traumatol Arthrosc. 2007 May;15(5):537-46
17187274
N Engl J Med. 2002 Jul 11;347(2):81-8
12110735
Arthritis Rheum. 1988 Jan;31(1):63-71
3345232
Acta Orthop Traumatol Turc. 2007 Nov-Dec;41(5):337-42
18180567
Clin Exp Rheumatol. 1983 Jan-Mar;1(1):41-4
6681123
Knee. 2008 Jun;15(3):159-63
18378147
Orthop Clin North Am. 2005 Oct;36(4):413-7
16164946
Curr Rheumatol Rep. 2007 Apr;9(1):31-5
17437664
Arthritis Rheum. 1999 Mar;42(3):475-82
10088770
Baillieres Clin Rheumatol. 1997 Nov;11(4):769-94
9429736
Arthroscopy. 1999 Mar;15(2):142-6
10210070
Arch Orthop Trauma Surg. 2002 Nov;122(8):451-3
12442182
Arthritis Rheum. 1998 May;41(5):778-99
9588729
J Rheumatol Suppl. 1993 Aug;39:3-9
8410881
Immunology. 1980 Jul;40(3):435-46
7429537
Clin Exp Rheumatol. 1989 May-Jun;7(3):247-50
2547540
Clin Orthop Relat Res. 2007 Feb;455:107-12
17279040
Drug Saf. 2000 Aug;23(2):115-30
10945374
J Rheumatol. 1995 Jul;22(7):1311-4
7562764
Osteoarthritis Cartilage. 2002 Sep;10(9):692-706
12202122
J Rheumatol. 2005 Jul;32(7):1317-23
15996071
J Am Acad Orthop Surg. 2002 Sep-Oct;10(5):356-63
12374486
J Rheumatol. 2005 Oct;32(10):1928-36
16206349
Clin Orthop Relat Res. 2007 Feb;455:113-22
17159579
Bull World Health Organ. 2003;81(9):646-56
14710506
Orthop Rev. 1990 Apr;19(4):371-3, 376-9
2185456
J Rheumatol. 1989 Jul;16(7):867-84
2527991
J Rheumatol. 2006 May;33(5):951-6
16652426